before few years, the united kingdom has witnessed a revolution in clinical bodyweight‑loss remedies — from the introduction of semaglutide (Wegovy®) towards the escalating reputation of tirzepatide (Mounjaro®). Now, another name is drawing awareness in each scientific and general public wellbein